1. Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer
   Ke Zhao et al, 2023, Medicine CrossRef
2. PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer
   Ahmad Reza Panahi Meymandi et al, 2024, Frontiers in Oncology CrossRef
3. Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature
   Linlin Liu et al, 2023, Diagnostic Pathology CrossRef
4. Role of Oxygenation Factor Hypoxia-inducible Factor-1α (HIF-1α) as Prognostic Indicators in Cervical Cancer
   I Wayan Megadhana et al, 2023, Journal of South Asian Federation of Obstetrics and Gynaecology CrossRef
5. A prognostic hypoxia gene signature is associated with a dampened tumour immune microenvironment in cervical cancer
   Salem Chouaib et al, 2023, Hamdan Medical Journal CrossRef
6. FOXP3 Isoforms Expression in Cervical Cancer: Evidence about the Cancer-Related Properties of FOXP3Δ2Δ7 in Keratinocytes
   Natalia Garcia-Becerra et al, 2023, Cancers CrossRef
7. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
   Zhengtian Li et al, 2021, Medicine CrossRef
8. Promising predictive molecular biomarkers for cervical cancer (Review)
   Marcela Lizano et al, 2024, International Journal of Molecular Medicine CrossRef